Bessemer Group’s Inogen INGN Stock Holding History

Bessemer Group’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-85	Closed	-$4K	–	1915
2021 Q3	$4K	Buy	+85	New	+$5.23K	﹤0.01%	1538
2017 Q4	–	Sell	-4,400	Closed	-$418K	–	1749
2017 Q3	$418K	Hold	4,400	–	–	﹤0.01%	885
2017 Q2	$420K	Hold	4,400	–	–	﹤0.01%	899
2017 Q1	$341K	Buy	+4,400	New	+$305K	﹤0.01%	972
2016 Q4	–	Sell	-5,600	Closed	-$335K	–	2000
2016 Q3	$335K	Buy	+5,600	New	+$312K	﹤0.01%	871

Other funds holding INGN

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bessemer Group's INGN Position: Q4 2021 in Review

Bessemer Group sold out of Inogen (INGN) in Q4 2021, closing a stake of 85 shares — an estimated $4K sold.

Bessemer Group first reported a position in INGN in Q3 2016 and held it in 5 quarters. The position peaked at $420K in Q2 2017. 168 funds tracked by Wall St. Rank hold INGN as of Q4 2021.

Bessemer Group reported no remaining Inogen position as of Q4 2021 after selling out during the quarter.
Bessemer Group sold 85 Inogen shares in Q4 2021, an estimated $4K.
Bessemer Group first reported a position in Inogen in Q3 2016 and held it in 5 quarters.
Bessemer Group's Inogen position peaked at $420K in Q2 2017.
168 funds tracked by Wall St. Rank held Inogen as of Q4 2021.

Based on Bessemer Group's 13F filing for Q4 2021, filed 27 Jan 2022.